Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-β1 production

Eun Wha Choi,I.-Rang Lim,Ji Hong Park,Jiwoo Song,Bongkum Choi,Sungjoo Kim
DOI: https://doi.org/10.1186/s13287-023-03523-0
2023-10-06
Stem Cell Research & Therapy
Abstract:Rheumatoid arthritis (RA) is a chronic and systemic autoimmune disease characterized by synovial inflammation-mediated progressive destruction of the cartilage and bone, resulting in reduced quality of life. We primed human telomerase reverse transcriptase-overexpressing immortalized human adipose tissue-derived mesenchymal stem cells (iMSCs) with serum derived from a non-human primate RA model and studied the immunomodulatory ability of exosomes obtained from primed iMSCs.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?